Barclays raised the firm’s price target on Crowdstrike to $240 from $225 and keeps an Overweight rating on the shares post the Q3 report. The company’s net new annual recurring revenue returned to growth, growing double digits both organically excluding Bionic and on a reported basis, the analyst tells investors in a research note. The analyst says Crowdstrike’s “platform story will gain steam.”
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRWD: